143 related articles for article (PubMed ID: 18951877)
1. Thymine-DNA glycosylase interacts with and functions as a coactivator of p53 family proteins.
Kim EJ; Um SJ
Biochem Biophys Res Commun; 2008 Dec; 377(3):838-42. PubMed ID: 18951877
[TBL] [Abstract][Full Text] [Related]
2. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
Kim EJ; Park JS; Um SJ
Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
[TBL] [Abstract][Full Text] [Related]
3. Thymine DNA glycosylase represses myocardin-induced smooth muscle cell differentiation by competing with serum response factor for myocardin binding.
Zhou J; Blue EK; Hu G; Herring BP
J Biol Chem; 2008 Dec; 283(51):35383-92. PubMed ID: 18945672
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of thymine DNA glycosylase (TDG) by the tumor suppressor protein p53.
da Costa NM; Hautefeuille A; Cros MP; Melendez ME; Waters T; Swann P; Hainaut P; Pinto LF
Cell Cycle; 2012 Dec; 11(24):4570-8. PubMed ID: 23165212
[TBL] [Abstract][Full Text] [Related]
5. Kinase activity-independent suppression of p73alpha by AMP-activated kinase alpha (AMPKalpha).
Lee YG; Lee SW; Sin HS; Kim EJ; Um SJ
Oncogene; 2009 Feb; 28(7):1040-52. PubMed ID: 19079340
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo.
Kim EJ; Park JS; Um SJ
J Biol Chem; 2002 Aug; 277(35):32020-8. PubMed ID: 11925430
[TBL] [Abstract][Full Text] [Related]
7. The role of p53 protein family in gastrointestinal malignancies.
Zaika AI; El-Rifai W
Cell Death Differ; 2006 Jun; 13(6):935-40. PubMed ID: 16557273
[No Abstract] [Full Text] [Related]
8. Tumor suppressors p53, p63TAα, p63TAy, p73α, and p73β use distinct pathways to repress telomerase expression.
Yao Y; Bellon M; Shelton SN; Nicot C
J Biol Chem; 2012 Jun; 287(24):20737-47. PubMed ID: 22496369
[TBL] [Abstract][Full Text] [Related]
9. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
[TBL] [Abstract][Full Text] [Related]
10. p53 family members: similar biochemistry, different biology.
Barbieri CE; Pietenpol JA
Cancer Biol Ther; 2005 Apr; 4(4):419-20. PubMed ID: 15908776
[No Abstract] [Full Text] [Related]
11. T:G mismatch-specific thymine-DNA glycosylase (TDG) as a coregulator of transcription interacts with SRC1 family members through a novel tyrosine repeat motif.
Lucey MJ; Chen D; Lopez-Garcia J; Hart SM; Phoenix F; Al-Jehani R; Alao JP; White R; Kindle KB; Losson R; Chambon P; Parker MG; Schär P; Heery DM; Buluwela L; Ali S
Nucleic Acids Res; 2005; 33(19):6393-404. PubMed ID: 16282588
[TBL] [Abstract][Full Text] [Related]
12. Deletion of the COOH-terminal region of p73alpha enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammalian cells.
Ozaki T; Naka M; Takada N; Tada M; Sakiyama S; Nakagawara A
Cancer Res; 1999 Dec; 59(23):5902-7. PubMed ID: 10606232
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic prospects for p73 and p63: rising from the shadow of p53.
Vilgelm A; El-Rifai W; Zaika A
Drug Resist Updat; 2008; 11(4-5):152-63. PubMed ID: 18801697
[TBL] [Abstract][Full Text] [Related]
14. Identification of protein kinase A catalytic subunit beta as a novel binding partner of p73 and regulation of p73 function.
Hanamoto T; Ozaki T; Furuya K; Hosoda M; Hayashi S; Nakanishi M; Yamamoto H; Kikuchi H; Todo S; Nakagawara A
J Biol Chem; 2005 Apr; 280(17):16665-75. PubMed ID: 15723830
[TBL] [Abstract][Full Text] [Related]
15. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif.
Minty A; Dumont X; Kaghad M; Caput D
J Biol Chem; 2000 Nov; 275(46):36316-23. PubMed ID: 10961991
[TBL] [Abstract][Full Text] [Related]
16. Cross-talks in the p53 family: deltaNp63 is an anti-apoptotic target for deltaNp73alpha and p53 gain-of-function mutants.
Lanza M; Marinari B; Papoutsaki M; Giustizieri ML; D'Alessandra Y; Chimenti S; Guerrini L; Costanzo A
Cell Cycle; 2006 Sep; 5(17):1996-2004. PubMed ID: 16931914
[TBL] [Abstract][Full Text] [Related]
17. PU.1 binding to the p53 family of tumor suppressors impairs their transcriptional activity.
Tschan MP; Reddy VA; Ress A; Arvidsson G; Fey MF; Torbett BE
Oncogene; 2008 May; 27(24):3489-93. PubMed ID: 18193090
[TBL] [Abstract][Full Text] [Related]
18. Analysis of molecular interactions of the p53-family p51(p63) gene products in a yeast two-hybrid system: homotypic and heterotypic interactions and association with p53-regulatory factors.
Kojima T; Ikawa Y; Katoh I
Biochem Biophys Res Commun; 2001 Mar; 281(5):1170-5. PubMed ID: 11243857
[TBL] [Abstract][Full Text] [Related]
19. Noncovalent SUMO-1 binding activity of thymine DNA glycosylase (TDG) is required for its SUMO-1 modification and colocalization with the promyelocytic leukemia protein.
Takahashi H; Hatakeyama S; Saitoh H; Nakayama KI
J Biol Chem; 2005 Feb; 280(7):5611-21. PubMed ID: 15569683
[TBL] [Abstract][Full Text] [Related]
20. The transcriptional repressor hDaxx potentiates p53-dependent apoptosis.
Gostissa M; Morelli M; Mantovani F; Guida E; Piazza S; Collavin L; Brancolini C; Schneider C; Del Sal G
J Biol Chem; 2004 Nov; 279(46):48013-23. PubMed ID: 15339933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]